BioXconomy is part of the Informa Connect Division of Informa PLC
Informa PLC
|
ABOUT US
|
INVESTOR RELATIONS
|
TALENT
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
About
Events
Advertise
Stay Updated
Stay Updated
Investment
Related Topics
VC/PE
Seed Funding
IPOs
Recent in
Investment
See All
Male being kept up at night and unable to sleep
Investment
Interest rates, IPOs, China, or Trump: What’s keeping investors up at night?
Interest rates, IPOs, China, or Trump: What’s keeping investors up at night?
by
Dan Stanton
Feb 20, 2025
4 Min Read
Francesco De Rubertis, co-founder and partner at Medicxi (left) and Graziano Seghezzi, managing partner at Sofinnova Partners (right).
Investment
Sofinnova and Medicxi talk M&A, patent cliffs, and China
Sofinnova and Medicxi talk M&A, patent cliffs, and China
by
Millie Nelson
Feb 17, 2025
6 Min Read
Innovation
Related Topics
Hubs
Academic Research
R&D Technology
Recent in
Innovation
See All
Male being kept up at night and unable to sleep
Investment
Interest rates, IPOs, China, or Trump: What’s keeping investors up at night?
Interest rates, IPOs, China, or Trump: What’s keeping investors up at night?
by
Dan Stanton
Feb 20, 2025
4 Min Read
Asia map on the globe
Hubs
Eyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and Illumina
Eyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and Illumina
by
Millie Nelson
Feb 18, 2025
4 Min Read
Partnering
Related Topics
Licensing
M&A
Deals
Best Practices
Recent in
Partnering
See All
Asia map on the globe
Hubs
Eyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and Illumina
Eyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and Illumina
by
Millie Nelson
Feb 18, 2025
4 Min Read
Clock with the words timing is everything in red
Investment
Timing’s everything: Novartis pays $925m to buy Anthos and bring back Phase III mAb
Timing’s everything: Novartis pays $925m to buy Anthos and bring back Phase III mAb
by
Millie Nelson
Feb 14, 2025
1 Min Read
Business Strategy
Related Topics
Scaling/Commercialization
Growth Strategy
ESG
Outsourcing
Legal
Recent in
Business Strategy
See All
Asia map on the globe
Hubs
Eyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and Illumina
Eyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and Illumina
by
Millie Nelson
Feb 18, 2025
4 Min Read
Steven fuller with a yellow background - Race in STEM founder and Director
ESG
Race in STEM: Countering the ugly truth of bias in life sciences
Race in STEM: Countering the ugly truth of bias in life sciences
by
Millie Nelson
Feb 12, 2025
8 Min Read
Home
DEI
DEI
Steven fuller with a yellow background - Race in STEM founder and Director
ESG
Race in STEM: Countering the ugly truth of bias in life sciences
Race in STEM: Countering the ugly truth of bias in life sciences
by
Millie Nelson
Feb 12, 2025
8 Min Read
the word deal written on blue blocks in white writing
Investment
JPM 2025: Gilead inks inflammatory deal with LEO
JPM 2025: Gilead inks inflammatory deal with LEO
by
Millie Nelson
Jan 20, 2025
2 Min Read
Investment
JPM 2025: J&J snaps up neuroscience biotech Intra-Cellular for $14.6bn
JPM 2025: J&J snaps up neuroscience biotech Intra-Cellular for $14.6bn
Jan 15, 2025
|
2 Min Read
by
Millie Nelson
, Editor
BIO-EUROPE COVERAGE
Novo Nordisk sign
Business Strategy
Lessons and blessings: The Novo Nordisk way
Lessons and blessings: The Novo Nordisk way
Michael May, PhD, President, CCRM discusses Canada as a place for life sciences in this video.
Hubs
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Shaking hands
Partnering
Picky pharma prone to better proven partners amid dealmaking downturn
Picky pharma prone to better proven partners amid dealmaking downturn
Hervé Ansanay, Biotech Alliance Manager, discusses the features of the RESEAU SATT - SATT NETWORK
Sponsored Content
RESEAU SATT, the Best of French Deep Tech
RESEAU SATT, the Best of French Deep Tech
Latest
Male being kept up at night and unable to sleep
Investment
Interest rates, IPOs, China, or Trump: What’s keeping investors up at night?
Interest rates, IPOs, China, or Trump: What’s keeping investors up at night?
Asia map on the globe
Hubs
Eyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and Illumina
Eyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and Illumina
Francesco De Rubertis, co-founder and partner at Medicxi (left) and Graziano Seghezzi, managing partner at Sofinnova Partners (right).
Investment
Sofinnova and Medicxi talk M&A, patent cliffs, and China
Sofinnova and Medicxi talk M&A, patent cliffs, and China
BIO-Europe Spring banner Milan Italy
Mar 17 - Mar 19, 2025
Mar 17 - Mar 19, 2025
Europe's Largest Springtime Biotech Partnering Event
REGISTER
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
Stay Updated